Andrew Huberman· PhD
what we had thought was that well maybe if everybody had measured Baseline blood oxytocin levels maybe some of these you know maybe there would have been more um positive outcomes
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
what we had thought was that well maybe if everybody had measured Baseline blood oxytocin levels maybe some of these you know maybe there would have been more um positive outcomes
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
and our thinking when we went into our clinical trial was what if um its blood oxytocin levels that there going to be a subset of individuals that just make less oxytocin humans and that maybe those are the individuals who could who stand to benefit the most from treatment